Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

647 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Active, not recruiting

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07387471

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 279178 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 277580 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 279173 Yoshida-gun, Fukui, Japan
  • Kyushu University Hospital /ID# 277582 Fukuoka, Japan
View all 17 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

NCT04680052

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • John Muir Health Clinical Research Center Concord, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 261 locations
View Trial Details
Active, not recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

NCT04464200

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

NCT06667687

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
  • Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
  • Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
  • START Mountain Region /ID# 267592 West Valley City, Utah, United States
View all 14 locations
View Trial Details
Active, not recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

NCT05753501

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Arizona Oncology - Tucson - Wilmot Road /ID# 252351 Tucson, Arizona, United States
  • UC Irvine Medical Center /ID# 263020 Orange, California, United States
  • Stanford University - Palo Alto /ID# 249683 Palo Alto, California, United States
  • Rocky Mountain Cancer Centers - Lone Tree /ID# 252237 Lone Tree, Colorado, United States
View all 51 locations
View Trial Details
Active, not recruiting

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

NCT03888105

Conditions
B-cell Non-Hodgkin Lymphoma (B-NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View all 119 locations
View Trial Details
Active, not recruiting

FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role

NCT04333524

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • CHU de Dijon Dijon, France
  • Saint Louis Hospital Paris, France
  • IUCT Oncopole Toulouse Toulouse, France
  • ASO SS. Antonio e Biagio e C. Arrigo Alessandria, AL, Italy
View all 25 locations
View Trial Details

Related conditions